Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Alzheimer's Disease

  Free Subscription


23.05.2022

2 Acta Neuropathol
1 Am J Geriatr Psychiatry
2 Ann Neurol
5 Brain
1 Curr Alzheimer Res
5 J Alzheimers Dis
3 J Am Geriatr Soc
1 J Neurochem
1 J Neurosci
1 MMWR Morb Mortal Wkly Rep
1 Nat Rev Neurol
1 Nature
1 Neurobiol Aging
4 Neurobiol Dis
1 Neurologia (Engl Ed)
3 Neurology
1 Neuropsychology
1 Neuroreport
1 Neuroscience
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Rev Neurol (Paris)


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Neuropathol

  1. PLOWEY ED, Bussiere T, Rajagovindan R, Sebalusky J, et al
    Alzheimer disease neuropathology in a patient previously treated with aducanumab.
    Acta Neuropathol. 2022 May 17. pii: 10.1007/s00401-022-02433.
    PubMed         Abstract available

  2. LLOYD GM, Sorrentino ZA, Quintin S, Gorion KM, et al
    Unique seeding profiles and prion-like propagation of synucleinopathies are highly dependent on the host in human alpha-synuclein transgenic mice.
    Acta Neuropathol. 2022;143:663-685.
    PubMed         Abstract available


    Am J Geriatr Psychiatry

  3. SANO M, Zhu CW, Neugroschl J, Grossman HT, et al
    Agitation in Cognitive Disorders: Use of the National Alzheimer's Coordinating Center Uniform Data Set (NACC-UDS) to Evaluate International Psychogeriatric Association Definition.
    Am J Geriatr Psychiatry. 2022 Apr 21. pii: S1064-7481(22)00393.
    PubMed         Abstract available


    Ann Neurol

  4. CORNELIS MC, Bennett DA, Weintraub S, Schneider JA, et al
    Caffeine Consumption and Dementia: Are Lewy Bodies the Link?
    Ann Neurol. 2022;91:834-846.
    PubMed         Abstract available

  5. GRATUZE M, Jiang H, Wang C, Xiong M, et al
    APOE Antibody Inhibits Abeta-Associated Tau Seeding and Spreading in a Mouse Model.
    Ann Neurol. 2022;91:847-852.
    PubMed         Abstract available


    Brain

  6. ZHU WM, Neuhaus A, Beard DJ, Sutherland BA, et al
    Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585171. doi: 10.1093.
    PubMed         Abstract available

  7. EISSMAN JM, Dumitrescu L, Mahoney ER, Smith AN, et al
    Sex differences in the genetic architecture of cognitive resilience to Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585174. doi: 10.1093.
    PubMed         Abstract available


  8. Correction to: Brain amyloid-beta oligomers in ageing and Alzheimer's disease.
    Brain. 2022 May 13. pii: 6585189. doi: 10.1093.
    PubMed        

  9. MORRISON MS, Aparicio HJ, Blennow K, Zetterberg H, et al
    Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
    Brain. 2022 May 13. pii: 6585495. doi: 10.1093.
    PubMed         Abstract available

  10. MORRIS JC, Weiner M, Xiong C, Beckett L, et al
    Autosomal dominant and sporadic late onset Alzheimer disease share a common in vivo pathophysiology.
    Brain. 2022 May 17. pii: 6587090. doi: 10.1093.
    PubMed         Abstract available


    Curr Alzheimer Res

  11. ABDUL AZIZ M, Md Ashraf G, Safiqul Islam M
    Link of BIN1, CLU and IDE gene polymorphisms with the susceptibility of Alzheimer's disease: evidence from a meta-analysis.
    Curr Alzheimer Res. 2022 May 11. pii: CAR-EPUB-123377.
    PubMed         Abstract available


    J Alzheimers Dis

  12. HELBOE L, Rosenqvist N, Volbracht C, Pedersen LO, et al
    Highly Specific and Sensitive Target Binding by the Humanized pS396-Tau Antibody hC10.2 Across a Wide Spectrum of Alzheimer's Disease and Primary Tauopathy Postmortem Brains.
    J Alzheimers Dis. 2022 May 9. pii: JAD220125. doi: 10.3233/JAD-220125.
    PubMed         Abstract available

  13. WELTY S, Thathiah A, Levine AS
    DNA Damage Increases Secreted Abeta40 and Abeta42 in Neuronal Progenitor Cells: Relevance to Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220030. doi: 10.3233/JAD-220030.
    PubMed         Abstract available

  14. ZHANG Y, Hu Y, Han Z, Geng Y, et al
    Cattle Encephalon Glycoside and Ignotin Ameliorate Palmitoylation of PSD-95 and Enhance Expression of Synaptic Proteins in the Frontal Cortex of a APPswe/PS1dE9 Mouse Model of Alzheimer's Disease.
    J Alzheimers Dis. 2022 May 9. pii: JAD220009. doi: 10.3233/JAD-220009.
    PubMed         Abstract available

  15. FERNANDES M, Chiaravalloti A, Manfredi N, Placidi F, et al
    Nocturnal Hypoxia and Sleep Fragmentation May Drive Neurodegenerative Processes: The Compared Effects of Obstructive Sleep Apnea Syndrome and Periodic Limb Movement Disorder on Alzheimer's Disease Biomarkers.
    J Alzheimers Dis. 2022 May 9. pii: JAD215734. doi: 10.3233/JAD-215734.
    PubMed         Abstract available

  16. ZHANG X, Guan Q, Li Y, Zhang J, et al
    Aberrant Cross-Tissue Functional Connectivity in Alzheimer's Disease: Static, Dynamic, and Directional Properties.
    J Alzheimers Dis. 2022 May 9. pii: JAD215649. doi: 10.3233/JAD-215649.
    PubMed         Abstract available


    J Am Geriatr Soc

  17. BRIESACHER BA, Olivieri-Mui BL, Koethe B, Saczynski JS, et al
    Psychoactive medication therapy and delirium screening in skilled nursing facilities.
    J Am Geriatr Soc. 2022;70:1517-1524.
    PubMed         Abstract available

  18. ONEY M, White L, Coe NB
    Out-of-pocket costs attributable to dementia: A longitudinal analysis.
    J Am Geriatr Soc. 2022;70:1538-1545.
    PubMed         Abstract available

  19. SHARMA RK, Teng A, Asirot MG, Taylor JO, et al
    Challenges and opportunities in conducting research with older adults with dementia during COVID-19 and beyond.
    J Am Geriatr Soc. 2022;70:1306-1313.
    PubMed         Abstract available


    J Neurochem

  20. LOURENCO MV, Hausmann L
    Editorial: Honouring John Hardy - A true pioneer in research.
    J Neurochem. 2022;161:316-319.
    PubMed         Abstract available


    J Neurosci

  21. TU G, Halawa A, Yu X, Gillman S, et al
    Outcome-Locked Cholinergic Signaling Suppresses Prefrontal Encoding of Stimulus Associations.
    J Neurosci. 2022;42:4202-4214.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  22. OMURA JD, McGuire LC, Patel R, Baumgart M, et al
    Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged >/=45 Years - United States, 2019.
    MMWR Morb Mortal Wkly Rep. 2022;71:680-685.
    PubMed         Abstract available


    Nat Rev Neurol

  23. KARIKARI TK, Ashton NJ, Brinkmalm G, Brum WS, et al
    Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility.
    Nat Rev Neurol. 2022 May 18. pii: 10.1038/s41582-022-00665.
    PubMed         Abstract available


    Nature

  24. KOZLOV M
    Will the FDA change how it vets drugs following the Alzheimer's debacle?
    Nature. 2022 May 13. pii: 10.1038/d41586-022-01316.
    PubMed        


    Neurobiol Aging

  25. XIAO X, Liao X, Zhou Y, Weng L, et al
    Variants in the Niemann-pick type C genes are not associated with Alzheimer's disease: a large case-control study in the Chinese population.
    Neurobiol Aging. 2022;116:49-54.
    PubMed         Abstract available


    Neurobiol Dis

  26. NORAMBUENA A, Sun X, Wallrabe H, Cao R, et al
    SOD1 mediates lysosome-to-mitochondria communication and its dysregulation by amyloid-beta oligomers.
    Neurobiol Dis. 2022;169:105737.
    PubMed         Abstract available

  27. LAMPINEN R, Belaya I, Saveleva L, Liddell JR, et al
    Neuron-astrocyte transmitophagy is altered in Alzheimer's disease.
    Neurobiol Dis. 2022;170:105753.
    PubMed         Abstract available

  28. BUHL E, Kim YA, Parsons T, Zhu B, et al
    Effects of Eph/ephrin signalling and human Alzheimer's disease-associated EphA1 on Drosophila behaviour and neurophysiology.
    Neurobiol Dis. 2022 May 12:105752. doi: 10.1016/j.nbd.2022.105752.
    PubMed         Abstract available

  29. ZENG Q, Li K, Luo X, Wang S, et al
    The association of enlarged perivascular space with microglia-related inflammation and Alzheimer's pathology in cognitively normal elderly.
    Neurobiol Dis. 2022 May 13:105755. doi: 10.1016/j.nbd.2022.105755.
    PubMed         Abstract available


    Neurologia (Engl Ed)

  30. ZUNIGA SANTAMARIA T, Yescas Gomez P, Fricke Galindo I, Gonzalez Gonzalez M, et al
    Pharmacogenetic studies in Alzheimer disease.
    Neurologia (Engl Ed). 2022;37:287-303.
    PubMed         Abstract available


    Neurology

  31. LI Z, Heckman MG, Kanekiyo T, Martens YA, et al
    Clinicopathologic Factors Associated With Reversion to Normal Cognition in Patients With Mild Cognitive Impairment.
    Neurology. 2022;98:e2036-e2045.
    PubMed         Abstract available

  32. FARNSWORTH VON CEDERWALD B, Josefsson M, Wahlin A, Nyberg L, et al
    Association of Cardiovascular Risk Trajectory With Cognitive Decline and Incident Dementia.
    Neurology. 2022;98:e2013-e2022.
    PubMed         Abstract available

  33. ASKEN BM, Tanner JA, VandeVrede L, Mantyh WG, et al
    Plasma P-tau181 and P-tau217 in Patients With Traumatic Encephalopathy Syndrome With and Without Evidence of Alzheimer Disease Pathology.
    Neurology. 2022 May 16. pii: WNL.0000000000200678.
    PubMed         Abstract available


    Neuropsychology

  34. GARCIA-MARTINEZ M, Sanchez-Juan P, Butler CR
    A review of accelerated long-term forgetting in Alzheimer's disease: Current situation and prospects.
    Neuropsychology. 2022 May 19. pii: 2022-62553-001. doi: 10.1037/neu0000827.
    PubMed         Abstract available


    Neuroreport

  35. WANG L, Sun J, Miao Z, Jiang X, et al
    Quercitrin improved cognitive impairment through inhibiting inflammation induced by microglia in Alzheimer's disease mice.
    Neuroreport. 2022;33:327-335.
    PubMed         Abstract available


    Neuroscience

  36. QU W, Canoll P, Hargus G
    Molecular insights into cell type-specific roles in alzheimer's disease: human induced pluripotent stem cell-based disease modeling.
    Neuroscience. 2022 May 12. pii: S0306-4522(22)00235.
    PubMed         Abstract available


    PLoS One

  37. ANDRADE JM, Pachar P, Trujillo L, Cartuche L, et al
    Suillin: A mixed-type acetylcholinesterase inhibitor from Suillus luteus which is used by Saraguros indigenous, southern Ecuador.
    PLoS One. 2022;17:e0268292.
    PubMed         Abstract available

  38. CANNAVO C, Cleverley K, Maduro C, Mumford P, et al
    Endosomal structure and APP biology are not altered in a preclinical mouse cellular model of Down syndrome.
    PLoS One. 2022;17:e0262558.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  39. LINSE S, Sormanni P, O'Connell DJ
    An aggregation inhibitor specific to oligomeric intermediates of Abeta42 derived from phage display libraries of stable, small proteins.
    Proc Natl Acad Sci U S A. 2022;119:e2121966119.
    PubMed         Abstract available


    Rev Neurol (Paris)

  40. DEVIANNE J, Mawet J, Hugon J, Roos C, et al
    Is there a link between headache and cognitive disorders? A systematic review.
    Rev Neurol (Paris). 2022;178:285-290.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: